HCPCS M1234: HCV Antibody Reactive with Viral Test Undetected - OpenPayer

Summary & Overview

HCPCS M1234: HCV Antibody Reactive with Viral Test Undetected

HCPCS Level II code M1234 represents a follow-up diagnostic designation for patients who screen reactive on an HCV antibody test but have a subsequent HCV viral test that does not detect viremia. Nationally, this distinction matters for accurate reporting of HCV screening outcomes, patient follow-up pathways, and public health surveillance. Proper use of the code clarifies care pathways for patients who are antibody-positive but RNA-negative, capturing a resolved infection, false positive antibody, or successful prior treatment.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and standard billing considerations tied to this diagnostic scenario. The publication outlines benchmarks and payer coverage patterns where available and highlights policy or coding updates that affect how follow-up HCV testing is documented on claims.

This summary equips billing professionals, clinical coders, and policy analysts with an understanding of when M1234 applies, why distinguishing antibody reactivity from active viremia is clinically and administratively important, and what topics to review next in the full publication (coverage detail, coding guidance, and implications for reporting and quality measurement).

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareM1234HCPCS Level IIHCV testingviral loadlaboratory billingfollow-up testinginfectious diseasediagnostic codingoutpatient lab

Billing Code Overview

HCPCS Level II code M1234 describes a clinical scenario in which a patient has a reactive hepatitis C virus (HCV) antibody test followed by a confirmatory HCV viral test that does not detect HCV viremia. This code is used to report the follow-up diagnostic finding after initial antibody screening.

Service type: Follow-up diagnostic laboratory testing and interpretation related to HCV screening
Typical site of service: Outpatient laboratory or clinic-based testing

Clinical & Coding Specifications

Clinical Context

A 34-year-old patient presents to an outpatient infectious disease clinic after routine screening with a reactive hepatitis C virus (HCV) antibody test. The clinic schedules a follow-up HCV RNA (viral) NAT (nucleic acid test) to determine active viremia. Phlebotomy is performed in the clinic lab; the specimen is sent to a reference laboratory. Results return as “HCV RNA not detected,” indicating no current viremia. The clinical workflow includes documentation of the reactive antibody with confirmatory RNA testing, notification of the patient with counseling on interpretation (past resolved infection, successful treatment, or false-positive antibody), updating problem list, and determining need for repeat testing or linkage to care. Typical sites of service include outpatient clinic, community health center, federally qualified health center, and hospital outpatient laboratory.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when services required substantially greater work than typical for the service performed (e.g., complex counseling or extended time coordinating care after unexpected results).
`23`	Unusual anesthesia

Related Codes

HCPCS-M1256-PRIOR-HISTORY-KNOWN-CVD

HCPCS M1256: Prior History of Known Cardiovascular Disease

HCPCS-M1210-HIGH-RISK-MEDICATION-ORDERS-NOT-ORDERED

HCPCS M1210: At Least Two High-Risk Medication Orders Not Ordered

HCPCS-M1152-HEART-TRANSPLANT-LVAD-PATIENT

HCPCS M1152: Heart Transplant or LVAD Patient

HCPCS-M1315-COLORECTAL-SCREENING-RESULTS-NOT-DOCUMENTED-REVIEWED

HCPCS Level II M1315: Colorectal Cancer Screening Results Not Documented and Reviewed

HCPCS-M1218-COPD-SYMPTOM-EVALUATION

HCPCS M1218: COPD Symptom Evaluation and Management

HCPCS-M1289-TOBACCO-USER-NO-CESSATION-INTERVENTION

HCPCS M1289: Tobacco User Without Cessation Intervention

HCPCS-M1475-HUNTINGTONS-DISEASE-CARE

HCPCS Level II M1475: Huntington's Disease Care

HCPCS-M1332-INADEQUATE-INITIAL-EVALUATION-FOLLOW-UP

HCPCS M1332: Inadequate Initial Evaluation or Missed 2-Week Re-evaluation

HCPCS-M1405-PATIENTS-RECURRENCE-DISEASE-PROGRESSION

HCPCS M1405: Patients with Recurrence or Disease Progression

HCPCS-M1374-RA-ADDITIONAL-ENCOUNTER-90-DAYS

HCPCS M1374: Additional Rheumatoid Arthritis Encounter, 90+ Days

Showing 1–10 of 356

Taxonomy Code	Specialty	Notes
207Q00000X	Infectious Disease	Specialists who interpret HCV testing and manage follow-up and linkage to care.
208000000X	Family Medicine	Primary care clinicians who order screening HCV antibody and follow up abnormal results.
207L00000X	Internal Medicine	Hospital-based or clinic internists coordinating diagnostic confirmation and management.
364A00000X	Phlebotomy	Providers performing specimen collection for HCV antibody and RNA testing.
261QM0800X	Clinical Laboratory Scientist	Professionals performing HCV RNA testing in certified laboratories.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z11.3`	Encounter for screening for infections with a predominantly sexual mode of transmission	Applies when HCV antibody testing is performed as screening in asymptomatic individuals.
`R75`	Inconclusive laboratory evidence of human immunodeficiency virus [HIV]	Example of lab-inconclusive code pattern; included for concept of follow-up testing.
`B18.2`	Chronic viral hepatitis C	Relevant when antibody reactive and RNA may determine chronic infection status.
`Z22.52`	Carrier of viral hepatitis C	Used when patient is a known carrier; confirmatory RNA testing helps determine active viremia.
`Z71.7`	Human immunodeficiency virus [HIV] counseling	Counseling interplay common in viral screening workflows; included due to overlapping counseling services.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36415`	Collection of venous blood by venipuncture	Commonly performed to obtain specimen for both HCV antibody screening and HCV RNA confirmatory testing.
`87521`	Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C virus, amplified probe technique	Represents HCV RNA qualitative or quantitative testing methods used to detect viremia; directly used for confirmatory viral testing.
`86803`	Antibody; hepatitis C (HCV)	Used for the initial HCV antibody screening that was reactive in this scenario.
`87443`	Infectious agent detection by nucleic acid (DNA or RNA), hepatitis C virus, amplified probe technique, quantitative	Used when a quantitative HCV RNA assay is performed to measure viral load when viremia is present; may be ordered alongside qualitative testing depending on clinical workflow.
`99000`	Handling and/or conveyance of specimen for transfer from physician's office to a laboratory	Used when the practice charges for specimen handling or courier services to a reference laboratory for HCV RNA testing.